MedTrace Logo

Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients

NCT02169141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2014-06-23

No results posted yet for this study

Summary

This is an open label observational pharmacokinetic drug study to evaluate Levofloxacine and Capreomycin in patients with Multidrug-Resistant Tuberculosis (MDR-TB).

Conditions

Interventions

OTHER

Pharmacokinetics

multiple blood samples are obtained by means of an indwelling intravenous catheter for calculating PK parameters

Sponsors & Collaborators

  • Republican Scientific and Practical Centre for Pulmonology and TB

    collaborator UNKNOWN

  • National Institute for Public Health and the Environment (RIVM)

    collaborator OTHER_GOV

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • JW C Alffenaar, PhD PharmD · UMCG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-02-28
Completion
2013-11-30

Countries

  • Belarus

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02169141 on ClinicalTrials.gov